We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+0.82%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$187B
AUM Growth
-$1.41B
Cap. Flow
-$2.94B
Cap. Flow %
-1.58%
Top 10 Hldgs %
24.38%
Holding
10,185
New
1,269
Increased
3,519
Reduced
3,507
Closed
1,718

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$940M
2
GLD icon
SPDR Gold Trust
GLD
+$375M
3
C icon
Citigroup
C
+$202M
4
GILD icon
Gilead Sciences
GILD
+$150M
5
M icon
Macy's
M
+$81.3M

Sector Composition

Rank Sector Weight
1 Technology 1.75%
2 Financials 1.43%
3 Consumer Discretionary 0.87%
4 Healthcare 0.87%
5 Energy 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NMM icon
8376
Navios Maritime Partners
NMM
$2.43B
$15K ﹤0.01%
765
-6,787
-90% -$146K
NMM icon
8377
PUT
Navios Maritime Partners
NMM
$2.43B
$15K ﹤0.01%
767
-11,493
-94% -$247K
SINT icon
8378
SiNtx Technologies
SINT
$10.5M
0
RADA
8379
DELISTED
Rada Electronic Industries Ltd
RADA
$15K ﹤0.01%
+12,651
New +$11.7K
ROX
8380
DELISTED
Castle Brands, Inc.
ROX
$15K ﹤0.01%
20,108
+4,545
+29% +$3.89K
HNR
8381
CALL
DELISTED
Harvest Natural Resources
HNR
$15K ﹤0.01%
4,475
CTIC
8382
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$15K ﹤0.01%
4,377
+567
+15% +$2.6K
ETRM
8383
PUT
DELISTED
EnteroMedics Inc.
ETRM
$15K ﹤0.01%
714
CRK icon
8384
CALL
Comstock Resources
CRK
$4.26B
$14K ﹤0.01%
3,360
-4,860
-59% -$19K
SMSI icon
8385
Smith Micro Software
SMSI
$16.6M
$14K ﹤0.01%
+150
New +$16.3K
VERU icon
8386
Veru
VERU
$47.7M
$14K ﹤0.01%
+1,121
New +$15.4K
VIRX
8387
CALL
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$14K ﹤0.01%
123
+5
+4% +$554
NLST
8388
DELISTED
Netlist, Inc.
NLST
$14K ﹤0.01%
12,084
-25,124
-68% -$31.7K
MATN
8389
DELISTED
Mateon Therapeutics, Inc.
MATN
$14K ﹤0.01%
+20,665
New +$14.6K
CTIC
8390
CALL
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$14K ﹤0.01%
4,190
-4,540
-52% -$20.8K
IPAS
8391
DELISTED
Ipass Inc Common Stock
IPAS
$13K ﹤0.01%
1,087
-3,641
-77% -$42.9K
ETRM
8392
DELISTED
EnteroMedics Inc.
ETRM
$13K ﹤0.01%
649
+364
+128% +$16.7K
CRTN
8393
DELISTED
Cartesian, Inc.
CRTN
$12K ﹤0.01%
+11,690
New +$17.6K
CGG
8394
DELISTED
CGG
CGG
$12K ﹤0.01%
+542
New +$14.3K
VSR
8395
DELISTED
Versar, Inc.
VSR
$12K ﹤0.01%
+10,665
New +$19.9K
ARP
8396
PUT
DELISTED
ATLAS RESOURCE PARTNERS L P COM UIT REPSTG LTD PTNRS
ARP
$12K ﹤0.01%
22,200
-17,600
-44% -$9.07K
EGY icon
8397
Vaalco Energy
EGY
$599M
$11K ﹤0.01%
+10,388
New +$11.1K
IMMP
8398
Immutep
IMMP
$56M
$11K ﹤0.01%
+3,531
New +$11.9K
VRDN icon
8399
Viridian Therapeutics
VRDN
$2.75B
$11K ﹤0.01%
+120
New +$14.7K
GMO
8400
DELISTED
General Moly, Inc.
GMO
$11K ﹤0.01%
30,449
-89,210
-75% -$32.3K

Similar funds

Jeff Yass's Q2 2016 Portfolio in Review

As of Q2 2016, Jeff Yass held 10,185 positions worth $187B, down 0.75% from $188B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Jeff Yass's Q2 2016 filing shows 1,269 new, 3,519 increased, 3,507 reduced and 1,718 closed positions. Its largest new stake was Vanguard Long-Term Bond ETF: 484,542 shares worth $47.5M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.28B.

By sector, the portfolio is most concentrated in Technology at 1.8% of assets, up from 1.6% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Jeff Yass's largest Q2 2016 buy was Vanguard Long-Term Bond ETF: 484,542 shares worth $47.5M.
  • Jeff Yass added most to Apple in Q2 2016, an estimated $940M increase.
  • Jeff Yass's biggest Q2 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.28B.
  • Jeff Yass fully exited iShares MSCI Emerging Markets ETF in Q2 2016, selling an estimated $700M.
  • Jeff Yass's ten largest holdings make up 24% of its $187B portfolio in Q2 2016.
  • Jeff Yass opened 1,269 new positions and closed 1,718 in Q2 2016.
  • Jeff Yass's portfolio value fell 0.75% quarter-over-quarter to $187B.

Based on Susquehanna International Group's 13F filing for Q2 2016, filed 15 Aug 2016.